Regular ArticleEffect of Lactobacillus casei on the Absorption of Nifedipine from Rat Small Intestine
References (27)
- et al.
The effect of oral feeding of Lactobacillus casei strain Shirota on immunoglobulin E production in mice
J. Dairy Sci.
(1998) - et al.
Metabolic extraction of nifedipine during absorption from rat small intestine
Drug Metab. Pharmacokin.
(2002) - et al.
Interaction of citrus juices with felodipine and nifedipine
Lancet
(1991) - et al.
Determination of kinetic parameters of a carrier-mediated transport in the perfused intestine by two-dimensional laminar flow model: effect of the unstirred water layer
Biochim. Biophys. Acta
(1986) - et al.
Lactobacillus casei alters hPEPT1-mediated glycylsarcosine uptake in Caco-2 cells
J. Nutr.
(2004) - et al.
Lactobacillus casei DN-114 001 inhibits the ability of adherent-invasive Escherichia coli isolated from Crohn's disease patients to adhere to and to invade intestinal epithelial cells
Appl. Environ. Microbiol.
(2005) - et al.
Antitumor activity of Lactobacillus casei in mice
Gann
(1981) - et al.
Antitumor activity of Lactobacillus casei on Lewis lung carcinoma and line-10 hepatoma in syngeneic mice and guinea pigs
Cancer Immunol. Immunother.
(1985) - et al.
Antitumor effect of intrapleural administration of Lactobacillus casei in mice
Cancer Immunol. Immunother.
(1988) - et al.
Prevention of onset in an insulin-dependant diabetes mellitus model, NOD mice, by oral feeding of Lactobacillus casei
Acta Pathol. Microbiol. Immunol. Scand.
(1997)
Antidiabetic effects of an oral administration of Lactobacillus casei in a non-insulin-dependent diabetes mellitus (NIDDM) model using KK-Ay mice
Endocr. J.
Lipoteichoic acids from Lactobacillus casei strains elicit strong tumor necrosisi factor alpha-inducing activities in macrophages through Toll-like receptor 2
Clin. Diagn. Lab. Immunol.
Down-regulation of cytochrome P450 proteins and its activities by Shiga-like toxin II from Escherichia coli O157:H7
Biochem. Pharmacol.
Cited by (16)
Exploring the potential impact of probiotic use on drug metabolism and efficacy
2023, Biomedicine and PharmacotherapyThe gut microbiota contributes to the modulation of intestinal CYP3A1 and P-gp in streptozotocin-induced type 1 diabetic rats
2021, European Journal of Pharmaceutical SciencesCitation Excerpt :The probiotic Escherichia coli Nissle 1917 affected CYP450 expression along the gastrointestinal tract of rats (Matuskova et al., 2010). Oral administration of Lactobacillus casei changed the expression or activity of CYP1A1, CYP2E1 and CYP3A9 in rats (Matuskova et al., 2011; Kato et al., 2007). The gut microbiota produces dozens of metabolites, such as short-chain fatty acids (SCFAs), amino acid metabolites and secondary bile acids, which have systemic effects on the host.
The role of gut microbiota in the pharmacokinetics of antihypertensive drugs
2018, Pharmacological ResearchCitation Excerpt :A recent study suggested that gut microbiota may modulate the metabolic activity of the intestinal mucosa. According to the report by Kato et al. [97], the probiotic bacterial species Lactobacillus casei seems to affect metabolic activity, probably the CYP3A4 enzyme activity in the intestinal mucosa. In that study, rats received L. casei orally for 4 weeks and nifedipine absorption was then evaluated in the rat small intestine.
Exploring the role of gut microbiota in advancing personalized medicine
2023, Frontiers in Microbiology